Skip to main content Skip to section navigation Skip to footer
Capricor Therapeutics, Inc.
  • Home
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisors (DMD)
  • Our Science
    • Deramiocel (Biologic Medicine)
    • Exosomes Technology
    • Publications
    • Strategic Partnerships
  • Pipeline
    • Pipeline
    • Duchenne Muscular Dystrophy Overview
    • Clinical Trials
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • In the News
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Overview
    • Leadership
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Latest Proxy Statement and Annual Report
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity
  • News & Events

  • Overview
  • Press Releases
  • In the News
  • IR Calendar
  • Presentations
  • Email Alerts
Jun 22, 2016 6:00 am EDT

Capricor Therapeutics to Present at JMP Life Sciences Conference

Jun 16, 2016 8:30 am EDT

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

May 31, 2016 7:00 am EDT

Capricor Therapeutics to Present at 2016 BIO International Convention

May 12, 2016 4:05 pm EDT

Capricor Therapeutics Provides Corporate Update and Reports First Quarter 2016 Financial Results

May 05, 2016 4:05 pm EDT

Capricor Therapeutics to Hold First Quarter 2016 Business Update and Financial Results Conference Call on May 12, 2016 at 4:30 p.m. EDT

Apr 04, 2016 8:30 am EDT

Capricor Therapeutics Announces DSMB Recommends Continuation of HOPE-Duchenne Clinical Trial

Mar 17, 2016 4:00 pm EDT

Capricor Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update

Mar 17, 2016 12:50 pm EDT

Capricor Awarded $3.4 Million Grant from California Institute for Regenerative Medicine

Mar 15, 2016 8:30 am EDT

Capricor Therapeutics Announces $4 Million Registered Direct Offering

Mar 10, 2016 8:00 am EST

Capricor Therapeutics to Hold Fourth Quarter 2015 Financial Results and Business Update Conference Call on March 17, 2016 at 4:30 p.m. EDT

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • …
  • Page 31
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
  • Visit us on Linkedin
  • Visit us on Facebook
  • Visit us on Instagram
  • Visit us on Twitter
©2025 Capricor Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Manage Cookie Preferences